Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025133916> ?p ?o ?g. }
- W3025133916 endingPage "1214" @default.
- W3025133916 startingPage "1214" @default.
- W3025133916 abstract "Metastatic CRC (mCRC) is a molecular heterogeneous disease. The aim of this review is to give an overview of molecular-driven treatment of mCRC patients.A review of clinical trials, retrospective studies and case reports was performed regarding molecular biomarkers with therapeutic implications.RAS wild-type status was confirmed as being crucial for anti-epidermal growth factor receptor (EGFR) monoclonal antibodies and for rechallenge strategy. Antiangiogenic therapies improve survival in first- and second-line settings, irrespective of RAS status, while tyrosine kinase inhibitors (TKIs) remain promising in refractory mCRC. Promising results emerged from anti-HER2 drugs trials in HER2-positive mCRC. Target inhibitors were successful for BRAFV600E mutant mCRC patients, while immunotherapy was successful for microsatellite instability-high/defective mismatch repair (MSI-H/dMMR) or DNA polymerase epsilon catalytic subunit (POLE-1) mutant patients. Data are still lacking on NTRK, RET, MGMT, and TGF-β, which require further research.Several molecular biomarkers have been identified for the tailored treatment of mCRC patients and multiple efforts are currently ongoing to increase the therapeutic options. In the era of precision medicine, molecular-biology-driven treatment is the key to impro patient selection and patient outcomes. Further research and large phase III trials are required to ameliorate the therapeutic management of these patients." @default.
- W3025133916 created "2020-05-21" @default.
- W3025133916 creator A5003848263 @default.
- W3025133916 creator A5004540717 @default.
- W3025133916 creator A5006557248 @default.
- W3025133916 creator A5007635105 @default.
- W3025133916 creator A5012233597 @default.
- W3025133916 creator A5012817229 @default.
- W3025133916 creator A5014806739 @default.
- W3025133916 creator A5017926586 @default.
- W3025133916 creator A5020767180 @default.
- W3025133916 creator A5028994536 @default.
- W3025133916 creator A5033536074 @default.
- W3025133916 creator A5034035272 @default.
- W3025133916 creator A5037658807 @default.
- W3025133916 creator A5040416952 @default.
- W3025133916 creator A5048129292 @default.
- W3025133916 creator A5051507235 @default.
- W3025133916 creator A5053528793 @default.
- W3025133916 creator A5056023187 @default.
- W3025133916 creator A5060227057 @default.
- W3025133916 creator A5063263109 @default.
- W3025133916 creator A5068234157 @default.
- W3025133916 creator A5073332364 @default.
- W3025133916 creator A5073763585 @default.
- W3025133916 creator A5074775264 @default.
- W3025133916 creator A5076153494 @default.
- W3025133916 creator A5076563915 @default.
- W3025133916 creator A5076940330 @default.
- W3025133916 creator A5080262303 @default.
- W3025133916 date "2020-05-13" @default.
- W3025133916 modified "2023-10-17" @default.
- W3025133916 title "Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer" @default.
- W3025133916 cites W1554710523 @default.
- W3025133916 cites W1573363574 @default.
- W3025133916 cites W1704277699 @default.
- W3025133916 cites W1875361486 @default.
- W3025133916 cites W1879988417 @default.
- W3025133916 cites W1922733886 @default.
- W3025133916 cites W1934094702 @default.
- W3025133916 cites W1940241680 @default.
- W3025133916 cites W1964321121 @default.
- W3025133916 cites W1966133006 @default.
- W3025133916 cites W1968170113 @default.
- W3025133916 cites W1968209756 @default.
- W3025133916 cites W1968881689 @default.
- W3025133916 cites W1974024530 @default.
- W3025133916 cites W1977267072 @default.
- W3025133916 cites W1980725734 @default.
- W3025133916 cites W1981711832 @default.
- W3025133916 cites W1984642649 @default.
- W3025133916 cites W1990026184 @default.
- W3025133916 cites W1993052102 @default.
- W3025133916 cites W1993780950 @default.
- W3025133916 cites W2000100421 @default.
- W3025133916 cites W2005348280 @default.
- W3025133916 cites W2005496035 @default.
- W3025133916 cites W2008264953 @default.
- W3025133916 cites W2034269086 @default.
- W3025133916 cites W2037900813 @default.
- W3025133916 cites W2043929834 @default.
- W3025133916 cites W2046867705 @default.
- W3025133916 cites W2054301472 @default.
- W3025133916 cites W2058849572 @default.
- W3025133916 cites W2061745177 @default.
- W3025133916 cites W2064854706 @default.
- W3025133916 cites W2077217407 @default.
- W3025133916 cites W2078966764 @default.
- W3025133916 cites W2081441817 @default.
- W3025133916 cites W2086619383 @default.
- W3025133916 cites W2097709626 @default.
- W3025133916 cites W2098354753 @default.
- W3025133916 cites W2100143432 @default.
- W3025133916 cites W2100490225 @default.
- W3025133916 cites W2100589633 @default.
- W3025133916 cites W2106789440 @default.
- W3025133916 cites W2108235590 @default.
- W3025133916 cites W2108455517 @default.
- W3025133916 cites W2111851685 @default.
- W3025133916 cites W2115735904 @default.
- W3025133916 cites W2121847974 @default.
- W3025133916 cites W2125447919 @default.
- W3025133916 cites W2125747689 @default.
- W3025133916 cites W2127081952 @default.
- W3025133916 cites W2128146359 @default.
- W3025133916 cites W2129577018 @default.
- W3025133916 cites W2129998117 @default.
- W3025133916 cites W2132946679 @default.
- W3025133916 cites W2133453529 @default.
- W3025133916 cites W2137910932 @default.
- W3025133916 cites W2144026946 @default.
- W3025133916 cites W2145247101 @default.
- W3025133916 cites W2145606954 @default.
- W3025133916 cites W2147209945 @default.
- W3025133916 cites W2147834058 @default.
- W3025133916 cites W2153782264 @default.
- W3025133916 cites W2156834559 @default.
- W3025133916 cites W2157769714 @default.